EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction and Prognostic Role of Left Ventricular Systolic Dysfunction in Family Screening for Dilated Cardiomyopathy and Non-Dilated Left Ventricular Cardiomyopathy

Eva Del Mestre, Alessia Paldino, Carola Pio Loco Detto Gava, Ilaria Gandin, Marta Gigli, Davide Stolfo, Martina Setti, Giovanni Maria Severini, Beatrice Spedicati, Stefania Lenarduzzi, Giorgia Girotto, Alessandro Folgheraiter und 6 weitere

European Journal of Heart Failure · 01.12.2025 · 27 (12) · 3260-3268

DOI: 10.1002/ejhf.3657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 13.04.2025. Verfasst von Eva Del Mestre und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy. Hauptthemen laut MEDLINE: Ventricular Dysfunction, Left, Cardiomyopathy, Dilated, Ventricular Function, Left. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The prognostic significance of detecting left ventricular (LV) systolic dysfunction during family screening programmes (FSPs) in relatives of probands affected by dilated (DCM) and non-dilated left ventricular (NDLVC) cardiomyopathies remain unclear. This study sought to evaluate the prognostic role of LV systolic dysfunction detection in relatives of DCM/NDLVC probands and to define the most accurate FSP. Methods and results Baseline and follow-up data of first-degree relatives of probands affected by DCM/NDLVC were collected. The primary outcome was all-cause death and heart transplantation. Secondary heart failure (HF) and arrhythmic outcomes were also included. A total of 492 first degree relatives were enrolled. During a median follow-up of 110 months (interquartile range 57–188 months), only subjects that previously developed LV systolic dysfunction had primary outcomes (19 vs. 0, p < 0.001) and secondary outcomes (HF: 12 vs. 0, p = 0.005; arrhythmic: 30 vs. 0, p < 0.001). Subjects with LV systolic dysfunction detected by FSP showed lower rate of primary outcomes (FSP: n = 19 [14%]; no-FSP: n = 40 [37%]; p < 0.001) and secondary arrhythmic outcomes (FSP: n = 18 [13%]; no-FSP: n = 41 [38%]; p < 0.001). In this setting, family history of arrhythmia and being carrier of a pathogenic/likely pathogenic variant are the main risk factors for LV systolic dysfunction, while LV global longitudinal strain (LV-GLS) and Holter electrocardiogram (ECG) showed a relevant role in terms of prediction of LV systolic dysfunction and outcomes.

Conclusions

Relatives of DCM/NDLVC probands who developed LV systolic dysfunction during a long follow-up had a significant increased risk of major adverse cardiovascular outcomes. However, LV systolic dysfunction detected by FSP showed a better prognosis. In this context, genetics, Holter ECG and LV-GLS demonstrated their functional role for disease and event prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular Dysfunction, LeftCardiomyopathy, DilatedVentricular Function, LeftHumansFemaleMalePrognosisMiddle AgedAdultSystoleFollow-Up StudiesEchocardiography

Stichwörter der Autor:innen

Dilated cardiomyopathyFamily screeningGeneticsNon‐dilated left ventricular cardiomyopathyRelatives

Autor:innen und Institutionen

  • Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • European Reference Network for rare, low-prevalence, or complex diseases of the Heart (ERN GUARD-Heart).
  • Biostatistics Unit, Department of Medicine, Surgery and Health Science, University of Trieste, Trieste, Italy.
  • Department of Cardiology, Cardio-Thoracic Department, University Hospital of Verona, Verona, Italy.
  • Institute for Maternal and Child Health - IRCCS 'Burlo Garofolo', Trieste, Italy.
  • Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

Zitieren

APA

Del Mestre, E., Paldino, A., Pio Loco Detto Gava, C., Gandin, I., Gigli, M., Stolfo, D., Setti, M., Severini, G. M., Spedicati, B., Lenarduzzi, S., Girotto, G., Folgheraiter, A., Rizzi, J. G., Korcova, R., Mestroni, L., Merlo, M., Dal Ferro, M., & Sinagra, G. (2025). Prediction and Prognostic Role of Left Ventricular Systolic Dysfunction in Family Screening for Dilated Cardiomyopathy and Non-Dilated Left Ventricular Cardiomyopathy. European Journal of Heart Failure, 27(12), 3260-3268. https://doi.org/10.1002/ejhf.3657

Vancouver

Del Mestre E, Paldino A, Pio Loco Detto Gava C, Gandin I, Gigli M, Stolfo D, et al. Prediction and Prognostic Role of Left Ventricular Systolic Dysfunction in Family Screening for Dilated Cardiomyopathy and Non-Dilated Left Ventricular Cardiomyopathy. European Journal of Heart Failure. 2025;27(12):3260-3268. doi:10.1002/ejhf.3657

BibTeX
@article{DelMestre2025,
  author = {Del Mestre, Eva and Paldino, Alessia and Pio Loco Detto Gava, Carola and Gandin, Ilaria and Gigli, Marta and Stolfo, Davide and Setti, Martina and Severini, Giovanni Maria and Spedicati, Beatrice and Lenarduzzi, Stefania and Girotto, Giorgia and Folgheraiter, Alessandro and Rizzi, Jacopo Giulio and Korcova, Renata and Mestroni, Luisa and Merlo, Marco and Dal Ferro, Matteo and Sinagra, Gianfranco},
  title = {Prediction and Prognostic Role of Left Ventricular Systolic Dysfunction in Family Screening for Dilated Cardiomyopathy and Non-Dilated Left Ventricular Cardiomyopathy},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {12},
  pages = {3260--3268},
  doi = {10.1002/ejhf.3657}
}
Kostenlos starten →